Schenck F - Search Results

1

Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.

Egberts F, Gutzmer R, Ugurel S, Becker JC, Trefzer U, Degen A, Schenck F, Frey L, Wilhelm T, Hassel JC, Schadendorf D, Livingstone E, Mauch C, Garbe C, Berking C, Rass K, Mohr P, Kaehler KC, Weichenthal M, Hauschild A. Egberts F, et al. Among authors: schenck f. Ann Oncol. 2011 Jul;22(7):1667-1674. doi: 10.1093/annonc/mdq648. Epub 2011 Jan 10. Ann Oncol. 2011. PMID: 21220519 Free article. Clinical Trial.

2

Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis.

Augustin M, Bauer A, Ertner K, von Kiedrowski R, Schenck F, Ramaker-Brunke J, Möller S, Fait A, Bastian M, Thaçi D. Augustin M, et al. Among authors: schenck f. Dermatol Ther (Heidelb). 2023 Mar;13(3):803-816. doi: 10.1007/s13555-023-00894-3. Epub 2023 Feb 4. Dermatol Ther (Heidelb). 2023. PMID: 36738405 Free PMC article.

3

Spontaneous regression of melanoma with distant metastases - report of a patient with brain metastases.

Satzger I, Schenck F, Kapp A, Gutzmer R. Satzger I, et al. Among authors: schenck f. Eur J Dermatol. 2006 Jul-Aug;16(4):454-5. Eur J Dermatol. 2006. PMID: 16935819 No abstract available.

4

Therapeutic use of erythropoietin in dermatooncology.

Satzger I, Schenck F, Thol F, Ganser A, Kapp A, Gutzmer R. Satzger I, et al. Among authors: schenck f. J Dtsch Dermatol Ges. 2007 Apr;5(4):280-5. doi: 10.1111/j.1610-0387.2007.06203.x. J Dtsch Dermatol Ges. 2007. PMID: 17376091 Review. English, German.

5

Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.

Satzger I, Völker B, Meier A, Schenck F, Kapp A, Gutzmer R. Satzger I, et al. Among authors: schenck f. Am J Surg Pathol. 2007 Aug;31(8):1175-80. doi: 10.1097/PAS.0b013e3180341ebc. Am J Surg Pathol. 2007. PMID: 17667539

6

Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha.

Satzger I, Meier A, Schenck F, Kapp A, Hauschild A, Gutzmer R. Satzger I, et al. Among authors: schenck f. Int J Cancer. 2007 Dec 1;121(11):2562-6. doi: 10.1002/ijc.22951. Int J Cancer. 2007. PMID: 17680564

7

Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature.

Satzger I, Küttler U, Völker B, Schenck F, Kapp A, Gutzmer R. Satzger I, et al. Among authors: schenck f. Dermatology. 2010;220(1):77-81. doi: 10.1159/000265558. Epub 2009 Dec 9. Dermatology. 2010. PMID: 19996579 Review.

8

The hand-foot-syndrome associated with medical tumor therapy - classification and management.

Degen A, Alter M, Schenck F, Satzger I, Völker B, Kapp A, Gutzmer R. Degen A, et al. Among authors: schenck f. J Dtsch Dermatol Ges. 2010 Sep;8(9):652-61. doi: 10.1111/j.1610-0387.2010.07449.x. Epub 2010 May 6. J Dtsch Dermatol Ges. 2010. PMID: 20482685 Review. English, German.

9

[Cutaneous side effects of medical tumor therapy].

Degen A, Alter M, Schenck F, Kapp A, Gutzmer R. Degen A, et al. Among authors: schenck f. Hautarzt. 2011 Jun;62(6):444-50. doi: 10.1007/s00105-010-2042-4. Hautarzt. 2011. PMID: 21503784 German.

10

Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study.

Trefzer U, Gutzmer R, Wilhelm T, Schenck F, Kähler KC, Jacobi V, Witthohn K, Lentzen H, Mohr P. Trefzer U, et al. Among authors: schenck f. J Immunother Cancer. 2014 Aug 19;2:27. doi: 10.1186/s40425-014-0027-z. eCollection 2014. J Immunother Cancer. 2014. PMID: 25324973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters